天津力生制药股份有限公司 第八届董事会第一次会议决议公告

Group 1 - The company held its first meeting of the eighth board of directors on November 13, 2025, with all nine directors present, complying with legal and regulatory requirements [2][3][4] - Zhang Ping was elected as the chairman of the eighth board of directors, with his term starting from the date of the meeting [3][4] - The board established several specialized committees, including the Strategy and Development Committee, Nomination Committee, Compensation and Assessment Committee, and Audit Committee [5][6] Group 2 - The board approved the appointment of Wang Fujun as the general manager, with his term also starting from the date of the meeting [6][7] - Three vice general managers were appointed: Long Changfeng, Liang Jiankang, and Guo Xiaoyan, with their terms aligned with the board's term [7][8] - Wang Jiaying was appointed as the financial director, and Ma Feifei was appointed as the board secretary, both with terms starting from the meeting date [8][9] Group 3 - The board approved the appointment of Zhang Guiling as the head of the Audit and Compliance Department and Liu Zilong as the securities representative, with their terms also starting from the meeting date [10][11] - The board discussed the achievement of the first unlock condition for the 2022 stock incentive plan, allowing 14 individuals to unlock a total of 112,728 shares, representing approximately 0.0438% of the company's total shares [21][34] Group 4 - The eighth board of directors consists of nine members, including five non-independent directors and three independent directors, ensuring compliance with regulatory requirements regarding board composition [39][40] - The company confirmed that all appointed members and directors meet the qualifications and have no disqualifying conditions as per relevant laws and regulations [45][46][47][48][49][50]